Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.

NCT00307307 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Established Carotid Atherosclerosis

Interventions

DRUG: Niacin/simvastatin compared to simvastatin alone at 2 doses

Sponsor

University of Pennsylvania

Collaborators

[object Object]
[object Object]
[object Object]